BRIEF published on 09/03/2024 at 13:05, 1 year 8 months ago Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox Gene Therapy Advanced Therapies Biopharmaceuticals Lentiviral Vectors Manufacturing Services
PRESS RELEASE published on 09/03/2024 at 13:00, 1 year 8 months ago Rentschler Biopharma introduces new lentiviral vector manufacturing toolbox for advanced therapies Rentschler Biopharma launches new lentiviral vector manufacturing toolbox for advanced therapies at UK site, enhancing advanced therapy offerings Gene Therapy Advanced Therapies Rentschler Biopharma Lentiviral Vector Manufacturing Toolbox
BRIEF published on 07/11/2024 at 14:05, 1 year 10 months ago Rentschler Biopharma dévoile une nouvelle ligne de production dans le Massachusetts Rentschler Biopharma Produits Biopharmaceutiques Massachusetts Ligne De Production
BRIEF published on 07/11/2024 at 14:05, 1 year 10 months ago Rentschler Biopharma Unveils New Production Line in Massachusetts Rentschler Biopharma Biopharmaceuticals Massachusetts Production Line
PRESS RELEASE published on 07/11/2024 at 14:00, 1 year 10 months ago Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational Rentschler Biopharma SE announces full operational status of new state-of-the-art production line in Massachusetts, marking largest expansion in company's history Expansion Manufacturing Biopharmaceuticals Rentschler Biopharma SE State-of-the-art Production Line
BRIEF published on 05/28/2024 at 13:05, 1 year 11 months ago Rentschler Biopharma nomme Patrick Meyer au poste de responsable mondial des ventes et de la gestion des alliances BD Rentschler Biopharma Produits Biopharmaceutiques Développement Des Affaires Patrick Meyer
BRIEF published on 05/28/2024 at 13:05, 1 year 11 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
PRESS RELEASE published on 05/28/2024 at 13:00, 1 year 11 months ago Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management Rentschler Biopharma appoints Patrick Meyer as Global Head BD Sales and Alliance Management, demonstrating commitment to client centricity and global business development Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer Alliance Management
BRIEF published on 05/02/2024 at 14:15, 2 years ago Rentschler Biopharma promeut Patrick Cushing au poste de vice-président des opérations pour sa filiale américaine Rentschler Biopharma Expansion De La Fabrication Produits Biopharmaceutiques Gestion Opérationnelle Patrick Cushing
BRIEF published on 05/02/2024 at 14:15, 2 years ago Rentschler Biopharma Promotes Patrick Cushing as VP Operations for U.S. Subsidiary Operational Management Rentschler Biopharma Biopharmaceuticals Manufacturing Expansion Patrick Cushing
Published on 05/15/2026 at 14:35, 2 hours 17 minutes ago NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
Published on 05/15/2026 at 14:30, 2 hours 22 minutes ago AIAI Holdings Corporation Expresses Appreciation to Revere Securities for Financial Advisory Support on Successful NASDAQ Direct Listing
Published on 05/15/2026 at 14:00, 2 hours 52 minutes ago CCL Industries Announces 2026 Annual and Special Shareholders' Meeting Results
Published on 05/15/2026 at 14:00, 2 hours 52 minutes ago First Canadian Graphite to Attend the Mining Investment Event in Quebec City
Published on 05/15/2026 at 14:00, 2 hours 52 minutes ago Underground Gold Potential Grows at Colosseum
Published on 05/15/2026 at 16:48, 4 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/15/2026 at 15:35, 1 hour 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 05/15/2026 at 15:34, 1 hour 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/15/2026 at 15:33, 1 hour 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 05/15/2026 at 15:08, 1 hour 44 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 hour 52 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 6 hours 42 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 7 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day 22 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
